1
|
Kaufman SS, Gondolesi GE and Fishbein TM:
Parenteral nutrition associated live disease. Semin Neonatol.
8:375–381. 2003. View Article : Google Scholar
|
2
|
Suchy FJ: Approach to the infant with
cholestasis. Liver Disease in Children. Suchy J, Sokol RJ and
Balistreri WF: 2nd edition. Lippincott, Williams & Wilkins;
Philadelphia, PA: pp. 187–194. 2001
|
3
|
Salvador A, Janezko M, Porat R, et al:
Randomized controlled trial of early parenteral nutrition cycling
to prevent cholestasis in very low birth weight infants. J Pediatr.
161:229–233. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Carter BA and Shulman RJ: Mechanisms of
disease: update on the molecular etiology and fundamentals of
parenteral nutrition associated cholestasis. Nat Clin Pract
Gastroenterol Hepatol. 4:277–287. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Duro D, Mitchell PD, Kalish LA, et al:
Risk factors for parenteral nutrition-associated liver disease
following surgical therapy for necrotizing enterocolitis: A Glaser
Pedratric Research Network Study [corrected]. J Pediatr
Gastroenterol Nutr. 52:595–600. 2011.PubMed/NCBI
|
6
|
Hamosh M: Enteral lipid digestion and
absorption. Neonatal Nutrition and Metabolism. 2nd edition.
Cambridge University Press; Cambridge: pp. 350–368. 2006,
View Article : Google Scholar
|
7
|
Nishimura M, Yamaguchi M, et al: Role of
soybean oil fat emulsion in the prevention of hepatic xenobiotic
transporter mRNA up- and down-regulation induced by overdose of
fat-free total parenteral nutrition in infant rats. Drug Metab
Pharmacokinet. 20:46–54. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Oude Elferink RPJ and Paulusma CC:
Function and pathophysiological importance of ABCB4 (MDR3
p-glycoprotein). Pflugers Arch. 453:601–610. 2007.PubMed/NCBI
|
9
|
Gotthardt D, Runz H, Keitel V, et al: A
mutation in the canalicular phospholipid transporter gene, ABCB4,
is associated with cholestasis, ductopenia, and cirrhosis in
adults. Hepatology. 48:1157–1166. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kubitz R, Bode J, Erhardt A, et al:
Cholestatic liver diseases from child to adult the diversity of
MDR3 disease. Z Gastroenterol. 49:728–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wendum D, Barbu V, Rosmorduc O, Arrive L,
Flejou JF and Poupon R: Aspects of liver pathology in adult
patients with MDR3/ABCB4 gene mutations. Virchows Arch.
460:291–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Erlinger S: Low phospholipid-associated
cholestasis and cholelithiasis. Clin Res Hepatol Gastroenterol.
36(Suppl 1): 536–540. 2012.
|
13
|
Blau J, Sridhar S, Mathieson S and Chawla
A: Effects of protein/nonprotein caloric intake on parenteral
nutrition associated cholestasis in premature infants weighing
600–1000 grams. JPEN J Parenter Enteral Nutr. 31:487–490.
2007.PubMed/NCBI
|
14
|
Barnett R and Larson G: A
phenol-chloroform protocol for extracting DNA from ancient samples.
Methods Mol Biol. 840:13–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Primer 5 software. http://www.sciencesoftware.com.cnuri.
Accessed June 01, 2011
|
16
|
GenBank. http://www.ncbi.nlm.nih.gov/web/Genbankuri.
Accessed June 01, 2011
|
17
|
BioEdit protein contrast software.
http://www.piaodown.comuri.
Accessed August 30, 2011
|
18
|
Pinto Cardoso G, Abily-Donval L, Chadie A,
et al: Epidemiological study of very preterm infants at Rouen
University Hospital changes in mortality, mobidity, and care over
11 years. Arch Pediatr. 20:156–163. 2013.(In French).
|
19
|
Lee SM, Namgung R, Park MS, et al: High
incidence of rickets in extremely low birth weight infants with
severe parenteral nutrition-associated cholestasis and
brochopulmonary dysplasia. J Korean Med Sci. 27:1552–1555. 2012.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Rafeey M, Golzar A and Javadzadeh A:
Cholestatic syndromes of infancy. Pak J Biol Sci. 11:1764–1767.
2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Clayton PT: Disorders of bile acid
synthesis. J Inherit Metab Dis. 34:593–604. 2011. View Article : Google Scholar
|
22
|
Pasmant E, Goussard P, Baranes L, et al:
First description of ABCB4 gene deletions in familial low
phospholipid-associated cholelithiasis and oral
contraceptives-induced cholestasis. Eur J Hum Genet. 20:277–282.
2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Poupon R, Barbu V, Chamouard P, Wndum D,
Rosmorduc O and Housset C: Combined features of low
phospholipid-associated cholelithiasis and progressive familial
intrahepatic cholestasis 3. Liver Int. 30:327–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Harikar W, Kansal S, Oude Elferink RP and
Angus P: Intrahepatic cholestasis of pregnancy: when should you
look further? World J Gastroenterol. 15:1126–1129. 2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Colombo C, Vajro P, Degiorgio D, et al:
Clinical features and genotype-phenotype correlations in children
with progressive familial intrahepatic cholestasis type 3 related
to ABCB4 mutations. J Pediatr Gastroenterol Nutr. 52:73–83. 2011.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Oude Elferink RP, Paulusma CC and Groen
AK: Hepatocanalicular transport defects: pathophysiologic
mechanisms of rare diseases. Gastroenterology. 130:908–925.
2006.PubMed/NCBI
|
27
|
Lincke CR, Smit JJ, van der Velde-Koerts T
and Borst P: Structure of the human MDR3 gene and physical mapping
of the human MDR locus. J Biol Chem. 266:5303–5310. 1991.PubMed/NCBI
|
28
|
Davit-Spraul A, Gonzales E, Baussan C and
Jacquemin E: The spectrum of liver diseases related to ABCB4 gene
mutations: pathophysiology and clinical aspects. Semin Liver Dis.
30:134–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lang T, Haberl M, Jung D, et al: Genetic
variability, haplotype structures and ethnic diversity of hepatic
transporters MDR3 (ABCB4) and bile salt export pump (ABCB11). Drug
Metab Dispos. 34:1582–1599. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Groen A, Romero MR, Kunne C, Hoosdally SJ,
et al: Complementary functions of the flippase ATP8B1 and the
floppase ABCB4 in maintaining canalicular membrane integrity.
Gastroenterology. 141:1927–1937. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Trauner M and Boyer JL: Bile salt
transporters: molecular characterization, function, and regulation.
Physiol Rev. 83:633–671. 2003.PubMed/NCBI
|
32
|
Kullak-Ublick GA, Stieger B and Meier PJ:
Enterohepatic bile salt transporters in normal physiology and liver
disease. Gastroenterology. 126:322–342. 2004. View Article : Google Scholar : PubMed/NCBI
|
33
|
Trauner M, Fickert P and Wagner M: MDR3
(ABCB4) defects: A paradigm for the genetics of adult cholestatic
syndromes. Semin Liver Dis. 27:77–98. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Denk GU, Bikker H, Lekanne Dit Deprez RH,
et al: ABCB4 deficiency: A family saga of early onset
cholelithiasis, sclerosing cholangitis and cirrhosis and a novel
mutation in the ABCB4 gene. Hepatol Res. 40:937–941. 2010.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Ziol M, Barbu V, Rosmorduc O, et al: ABCB4
heterozygous gene mutations associated with fibrosing cholestatic
liver disease in adults. Gastroenterology. 135:131–141. 2008.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Mbongo-Kama E1, Harnois F, Mennecier D,
Leclercq E, Burnat P and Ceppa F: MDR3 mutations associated with
intrahepatic and gallbladder cholesterol cholelithiasis: an update.
Ann Hepatol. 6:143–149. 2007.PubMed/NCBI
|